TEVA PHARMACEUTICAL INDUSTRIES LIMITED
A190FK | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 4,500 % bis 01.03.2025 | finanzen.net
Teva Pharmaceutical Finance Netherlands III B.V. Teva Pharmaceutical Finance Netherlands II B.V.
TEVA Institutional Ownership - Teva Pharmaceutical Industries Ltd. (NYSE) Stock
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
PharmaBoardroom - Teva Pharma Belgium
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
TEVVF Institutional Ownership - Teva Pharmaceutical Industries, 7.00% Mandatory Convertible Preferred Shares (OTC) Stock
US88165FAG72 Institutional Ownership - Teva Pharmaceutical Fin Bv 2.95% 12/18/22
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
EX-99.1
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
424B3
Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024 | Business Wire
Teva Pharmaceutical Finance Iv BV (Teva Pharmaceutical Finance IV B.V.), Curaçao
PharmaBoardroom - Teva Netherlands
ağır insansız cümle teva pharmaceutical finance netherlands ii bv - shreesuppliers.com
A1ZZHS | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,250 % bis 31.03.2023 | finanzen.net
A3KYL4 | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 3,750 % bis 09.05.2027 | finanzen.net
UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT ONTARIO TEACHERS' PENSION PLAN BOARD, Individually and as Lead Plaintiff
Teva Pharmaceutical Finance Netherlands II B.V. Teva Pharmaceutical Finance Netherlands III B.V.
